Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION

Filed by E3 STRATEGIC CONSULTING GROUP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 13, 2025
Income
$50,000.00
Expenses
Not reported
Filing UUID
fd543d98-d1b1-4c9c-8702-b95890ddb03f
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" Urged Members and Staff to attend a congressional presentation on US construction jobs in the pharmaceutical industry;

Literal federal measure citations: S. 1040, H.R.1492, H.R. 4317, H.R. 5256

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.